From: Development and validation of stability-indicating UPLC method for the determination of gliclazide and its impurities in pharmaceutical dosage forms
System suitability parameters
Observed value
Acceptance criteria
USP plate count
8047
b2000
Tailing factor
1.3
c2.0
% Relative standard deviationa
0.84